HQY HEALTHEQUITY, INC.
Services-Business Services, NEC · Nasdaq · SEC CIK 1428336 · Fiscal year ends 01/31
Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.3%
TTM net income YoY62.2%
TTM EPS YoY67.9%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR164.2%
Margins
Gross margin71.2%
Operating margin25.8%
Net margin17.4%
FCF margin35.8%
EBITDA margin31.5%
Returns
ROE11.4%
ROA7.1%
ROIC (approx.)9.8%
Asset turnover0.41x
Leverage & solvency
Liabilities / assets39.2%
Debt / equity0.47x
Current ratio2.99x
Interest coverage6.69x
Cash quality & payout
Operating cash flow / net income2.07x
Accruals ratio-7.6%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-01-31 | FY20252025-01-31 | FY20242024-01-31 | FY20232023-01-31 | FY20222022-01-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.31B | $1.20B | $999.59M | $861.75M | $756.56M |
| Cost of revenue | $400.31M | $422.51M | $376.95M | $369.81M | $331.79M |
| Gross profit | $913.12M | $777.26M | $622.64M | $491.94M | $424.76M |
| R&D expense | $262.51M | $239.51M | $218.81M | $193.38M | $157.36M |
| SG&A expense | $119.93M | $132.26M | $103.66M | $97.47M | $85.44M |
| Operating income | $322.46M | $162.33M | $117.70M | $9.06M | -$24.24M |
| Interest expense | $57.13M | $60.63M | $55.45M | $48.42M | $36.57M |
| Pretax income | $277.43M | $116.03M | $75.04M | -$38.10M | -$66.74M |
| Income tax | $62.23M | $19.33M | $19.33M | -$11.95M | -$22.45M |
| Net income | $215.20M | $96.70M | $55.71M | -$26.14M | -$44.29M |
| EBITDA | $477.11M | $324.79M | $270.78M | $170.26M | $112.95M |
| EPS (basic) | 2.50 | 1.11 | 0.65 | -0.31 | -0.53 |
| EPS (diluted) | 2.46 | 1.09 | 0.64 | -0.31 | -0.53 |
| Weighted avg. shares (diluted) | 87.47M | 88.83M | 86.96M | 84.44M | 83.13M |
| Balance sheet | |||||
| Cash & equivalents | $318.93M | $295.95M | $403.98M | $254.27M | $225.41M |
| Receivables | $123.70M | $118.01M | $104.89M | $96.83M | $87.43M |
| Current assets | $512.28M | $477.75M | $557.44M | $382.89M | $351.34M |
| PP&E, net | $3.18M | $3.24M | $6.01M | $12.86M | $23.37M |
| Goodwill | $1.65B | $1.65B | $1.65B | $1.65B | $1.65B |
| Intangibles | $1.10B | $1.20B | $835.95M | $936.36M | $973.14M |
| Total assets | $3.38B | $3.45B | $3.16B | $3.09B | $3.11B |
| Current liabilities | $156.85M | $156.32M | $117.09M | $131.06M | $153.19M |
| Short-term debt | $0 | $0 | $0 | $17.50M | $8.75M |
| Long-term debt | $957.38M | $1.06B | $874.97M | $907.84M | $922.08M |
| Total debt | $957.38M | $1.06B | $874.97M | $925.34M | $930.83M |
| Total liabilities | $1.27B | $1.33B | $1.13B | $1.19B | $1.25B |
| Shareholders' equity | $2.11B | $2.11B | $2.04B | $1.90B | $1.85B |
| Net debt | $638.45M | $760.35M | $470.99M | $671.07M | $705.41M |
| Shares outstanding | 85.01M | 86.54M | 86.13M | 84.76M | 83.78M |
| Cash flow statement | |||||
| Operating cash flow | $457.09M | $339.86M | $242.83M | $150.65M | $141.00M |
| Capital expenditure | $1.97M | $2.08M | $1.69M | $3.37M | $8.91M |
| Free cash flow | $455.12M | $337.77M | $241.13M | $147.28M | $132.09M |
| Investing cash flow | -$47.14M | -$505.45M | -$46.07M | -$119.13M | -$639.25M |
| Financing cash flow | -$386.98M | $57.57M | -$47.04M | -$2.67M | $394.86M |
| Depreciation & amortization | $154.66M | $162.45M | $153.08M | $161.20M | $137.19M |
| Stock-based compensation | $73.06M | $96.42M | $77.15M | $62.61M | $52.75M |
| Share buybacks | $299.25M | $121.49M | $0 | $0 | — |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.